Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure | Scientific Reports – Nature.com

Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 12951310 (2020).

CAS Article Google Scholar

Baum, A. et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science 369, 10141018 (2020).

ADS CAS Article Google Scholar

Van Egeren, D. et al. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein. PLOS ONE 16, e0250780 (2021).

Article Google Scholar

Abdool Karim, S. S. & de Oliveira, T. New SARS-CoV-2 variantsclinical, public health, and vaccine implications. N. Engl. J. Med. 6, 67 (2021).

Google Scholar

Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science https://doi.org/10.1126/science.abg3055 (2021).

Article PubMed PubMed Central Google Scholar

Tada, T. et al. Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies. bioRxiv https://doi.org/10.1101/2021.02.18.431897 (2021).

Article PubMed PubMed Central Google Scholar

Tegally, H. et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv https://doi.org/10.1101/2020.12.21.20248640 (2020).

Article PubMed PubMed Central Google Scholar

Sabino, E. C. et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. The Lancet 397, 452455 (2021).

CAS Article Google Scholar

Kemp, S. A. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature https://doi.org/10.1038/s41586-021-03291-y (2021).

Article PubMed PubMed Central Google Scholar

Choi, B. et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N. Engl. J. Med. 383, 22912293 (2020).

Article Google Scholar

Valesano, A. L. et al. Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts. bioRxiv https://doi.org/10.1101/2021.01.19.427330 (2021).

Article PubMed PubMed Central Google Scholar

Baang, J. H. et al. Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient. J. Infect. Dis. 223, 2327 (2021).

CAS Article Google Scholar

Truong, T. T. et al. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv https://doi.org/10.1101/2021.02.27.21252099 (2021).

Article PubMed PubMed Central Google Scholar

Avanzato, V. A. et al. Case study: Prolonged infectious SARS-CoV-2 Shedding from an asymptomatic immunocompromised individual with cancer. Cell 183, 1901-1912.e9 (2020).

CAS Article Google Scholar

Rueca, M. et al. Compartmentalized replication of SARS-Cov-2 in upper vs. lower respiratory tract assessed by whole genome quasispecies analysis. Microorganisms 8, 66 (2020).

Article Google Scholar

Ramazzotti, D. et al. VERSO: A comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples. Patterns 2, 100212 (2021).

Article Google Scholar

Jary, A. et al. Evolution of viral quasispecies during SARS-CoV-2 infection. Clin. Microbiol. Infect. https://doi.org/10.1016/j.cmi.2020.07.032 (2020).

Article PubMed PubMed Central Google Scholar

Capobianchi, M. R. et al. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin. Microbiol. Infect. 26, 954956 (2020).

CAS Article Google Scholar

Armero, A., Berthet, N. & Avarre, J.-C. Intra-host diversity of SARS-Cov-2 should not be neglected: Case of the state of Victoria, Australia. Viruses 13, 133 (2021).

CAS Article Google Scholar

Xu, Y. et al. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence. J. Genet. Genomics 47, 610617 (2020).

Article Google Scholar

Popa, A. et al. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci. Transl. Med. 12, 66 (2020).

Article Google Scholar

Lythgoe, K. A. et al. SARS-CoV-2 within-host diversity and transmission. Science https://doi.org/10.1126/science.abg0821 (2021).

Article PubMed PubMed Central Google Scholar

Pfefferle, S. et al. SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany. Clin. Microbiol. Infect. 27(130), e5-130.e8 (2021).

Google Scholar

James, S. E. et al. High resolution analysis of transmission dynamics of Sars-Cov-2 in two major hospital outbreaks in South Africa leveraging intrahost diversity. medRxiv https://doi.org/10.1101/2020.11.15.20231993 (2020).

Article PubMed PubMed Central Google Scholar

Shen, Z. et al. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin. Infect. Dis. 71, 713720 (2020).

CAS Article Google Scholar

Wang, D. et al. Population bottlenecks and intra-host evolution during human-to-human transmission of SARS-CoV-2. Front. Med. 8, 66 (2021).

ADS CAS Google Scholar

Goyal, A., Reeves, D. & Schiffer, J. T. Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance. medRxiv https://doi.org/10.1101/2021.03.23.21254185 (2021).

Article PubMed PubMed Central Google Scholar

Wlfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465469 (2020).

ADS Article Google Scholar

Focosi, D. & Maggi, F. Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines. Rev. Med. Virol. https://doi.org/10.1002/rmv.2231 (2021).

Article PubMed PubMed Central Google Scholar

Grint, D. J. et al. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February. Euro Surveill 26, 66 (2021).

Article Google Scholar

Grabowski, F., Preibisch, G., Giziski, S., Kochaczyk, M. & Lipniacki, T. SARS-CoV-2 variant of concern 202012/01 has about twofold replicative advantage and acquires concerning mutations. Viruses 13, 66 (2021).

Article Google Scholar

Cele, S. et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature https://doi.org/10.1038/s41586-021-03471-w (2021).

Article PubMed Google Scholar

Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.. bioRxiv https://doi.org/10.1101/2021.01.25.428137 (2021).

Article PubMed PubMed Central Google Scholar

Widera, M. et al. Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro. medRxiv https://doi.org/10.1101/2021.02.24.21252372 (2021).

Article Google Scholar

Shen, X. et al. Neutralization of SARS-CoV-2 variants B.1.429 and B.1.351. N. Engl. J. Med. 6, 66 (2021).

Google Scholar

Garcia-Beltran, W. F. et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. medRxiv https://doi.org/10.1101/2021.02.14.21251704 (2021).

Article PubMed PubMed Central Google Scholar

Madhi, S. A. et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N. Engl. J. Med. 6, 66 (2021).

Google Scholar

Kissler, S. M. et al. Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2. medRxiv https://doi.org/10.1101/2021.02.16.21251535 (2021).

Article PubMed PubMed Central Google Scholar

Domingo, E. & Perales, C. Viral quasispecies. PLoS Genet 15, e1008271 (2019).

CAS Article Google Scholar

CDC. COVID-19 Quarantine and Isolation. Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/your-health/quarantine-isolation.html (2021).

CDC. Ending Isolation and Precautions for People with COVID-19: Interim Guidance. Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html (2021).

Marks, M. et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: A cohort study. Lancet Infect. Dis. 6, 66 (2021).

Google Scholar

CDC. COVID-19 and Your Health. Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/end-home-isolation.html (2020).

van Kampen, J. J. A. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat. Commun. 12, 267 (2021).

Article Google Scholar

La Scola, B. et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur. J. Clin. Microbiol. Infect. Dis. https://doi.org/10.1007/s10096-020-03913-9 (2020).

Article PubMed PubMed Central Google Scholar

Rhee, C., Kanjilal, S., Baker, M. & Klompas, M. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: When is it safe to discontinue isolation?. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa1249 (2020).

Article PubMed Central Google Scholar

Rodrguez-Grande, C. et al. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2. J. Clin. Microbiol. 59, 66 (2021).

Article Google Scholar

Dimcheff, D. E. et al. SARS-CoV-2 total and subgenomic RNA viral load in hospitalized patients. medRxiv https://doi.org/10.1101/2021.02.25.21252493 (2021).

Article PubMed PubMed Central Google Scholar

Lavine, J. S., Bjornstad, O. N. & Antia, R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science 371, 741745 (2021).

ADS CAS Article Google Scholar

Herbeck, J. T. et al. Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. AIDS 26, 193205 (2012).

Article Google Scholar

Watanabe, T. & Kawaoka, Y. Pathogenesis of the 1918 pandemic influenza virus. PLoS Pathog. 7, 66 (2011).

Google Scholar

Marshall, I. D. & Fenner, F. Studies in the epidemiology of infectious myxomatosis of rabbits. V. Changes in the innate resistance of Australian wild rabbits exposed to myxomatosis. J. Hyg. (Lond.) 56, 288302 (1958).

Read more:

Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure | Scientific Reports - Nature.com